Introduction: Preparing for regulatory and internal audits is a critical skill for M.Pharm students who will participate in pharmaceutical quality systems, documentation, and compliance activities. This quiz set focuses on audit preparation and strategy, covering inspection readiness, audit planning, evidence management, data integrity (ALCOA+), supplier qualification, mock audits, CAPA, and regulatory expectations from agencies like FDA and EMA. Questions are designed to strengthen your understanding of documentation practices, risk-based auditing, auditor roles, and post-audit follow-up so you can confidently design, execute, and support audits within manufacturing, clinical, and quality environments.
Q1. Which primary objective should a pharmaceutical audit plan address to ensure effective inspection readiness?
- Maximizing batch release speed
- Verifying compliance of documented processes with applicable regulations and internal procedures
- Reducing headcount in the quality unit
- Minimizing the number of recorded deviations
Correct Answer: Verifying compliance of documented processes with applicable regulations and internal procedures
Q2. Which document is most important to demonstrate data integrity during an audit?
- Batch manufacturing record with original signatures and audit trails
- Employee annual appraisal forms
- Marketing strategy presentation
- Purchase requisition forms
Correct Answer: Batch manufacturing record with original signatures and audit trails
Q3. ALCOA+ principles primarily help auditors assess which aspect of pharmaceutical documentation?
- Financial accuracy of procurement records
- Quality of marketing claims
- Data integrity and trustworthiness of records
- Effectiveness of training programs
Correct Answer: Data integrity and trustworthiness of records
Q4. What is the best first step when preparing an audit checklist for a supplier audit?
- Requesting price quotes
- Reviewing supplier-specific contractual requirements and previous audit reports
- Scheduling an immediate on-site visit without pre-assessment
- Conducting a full product performance test
Correct Answer: Reviewing supplier-specific contractual requirements and previous audit reports
Q5. During an audit, the auditor notices a recurrent deviation with unclear root cause. Which tool is most appropriate to identify the underlying reason?
- Five Whys or Fishbone (Ishikawa) analysis
- Simple majority voting
- Payroll reconciliation
- Facility floor plan review
Correct Answer: Five Whys or Fishbone (Ishikawa) analysis
Q6. Which of the following is a key benefit of conducting mock inspections before regulatory audits?
- Guaranteeing absence of any nonconformities
- Identifying documentation and operational gaps under simulated inspection conditions
- Lowering production costs for the next quarter
- Replacing the need for formal internal audits
Correct Answer: Identifying documentation and operational gaps under simulated inspection conditions
Q7. In a risk-based auditing approach, how should audit frequency be allocated?
- Equal frequency for all processes regardless of risk
- Less frequent audits for high-risk areas
- Higher frequency for high-risk processes and critical suppliers
- Only audit when a customer complaint occurs
Correct Answer: Higher frequency for high-risk processes and critical suppliers
Q8. Which evidence type is considered strongest when demonstrating compliance for a critical control during an audit?
- Witness testimony from a former employee
- Handwritten notes stored on a personal device
- Time-stamped electronic records with immutable audit trails
- Verbal assurance from a vendor representative
Correct Answer: Time-stamped electronic records with immutable audit trails
Q9. Which regulatory citation relates most directly to computerized system controls and electronic records in the U.S.?
- 21 CFR Part 210
- 21 CFR Part 11
- ICH Q8
- ISO 9001:2015 clause on leadership
Correct Answer: 21 CFR Part 11
Q10. What is the correct immediate action when an auditor identifies a critical observation during a regulatory inspection?
- Conceal the issue to avoid a 483
- Interrupt the inspection and refuse to cooperate
- Document the observation, provide factual information, and propose immediate containment if possible
- Send a legal notice to the inspector
Correct Answer: Document the observation, provide factual information, and propose immediate containment if possible
Q11. For audit documentation, which practice best supports reproducibility and traceability of conclusions?
- Using handwritten summaries without references
- Recording objective evidence, cross-references to source documents, and rationale for audit findings
- Keeping audit notes only in auditors’ personal emails
- Providing verbal conclusions without written reports
Correct Answer: Recording objective evidence, cross-references to source documents, and rationale for audit findings
Q12. Which metric is most useful for monitoring the effectiveness of the audit program over time?
- Number of cafeteria visits by auditors
- Percentage of audit findings closed with verified corrective actions within agreed timelines
- Total pages in the audit report
- Audit team’s social media followers
Correct Answer: Percentage of audit findings closed with verified corrective actions within agreed timelines
Q13. What characteristic distinguishes a major nonconformity from a minor one in a GMP audit?
- Major nonconformity has no impact on product quality
- Major nonconformity indicates a system failure that could lead to product quality or patient safety impact
- Minor nonconformity requires product recall
- Minor nonconformity is never documented
Correct Answer: Major nonconformity indicates a system failure that could lead to product quality or patient safety impact
Q14. Which element is essential in an effective CAPA plan following audit findings?
- Undefined responsibilities to allow flexibility
- Clear root cause identification, corrective and preventive actions, assigned owners, timelines, and verification methods
- Actions limited to retraining only
- Only documenting the problem without follow-up
Correct Answer: Clear root cause identification, corrective and preventive actions, assigned owners, timelines, and verification methods
Q15. When planning an audit scope for a clinical trial site, which documentation should be prioritized for review?
- Study protocol, informed consent forms, source documents, and investigational product accountability records
- Local cafeteria menus
- Marketing brochures for unrelated products
- Public social media posts by site staff
Correct Answer: Study protocol, informed consent forms, source documents, and investigational product accountability records
Q16. Which practice helps maintain auditor independence and impartiality?
- Auditing areas where the auditor has direct operational responsibility
- Having auditors rotate responsibilities and avoid auditing areas where they previously implemented procedures
- Allowing auditors to approve their own corrective actions
- Recruiting auditors from the same functional team they will audit
Correct Answer: Having auditors rotate responsibilities and avoid auditing areas where they previously implemented procedures
Q17. Which audit sampling approach is most appropriate when inspecting a batch production record with many repetitive entries?
- Random or statistically based sampling focusing on critical steps and trend analysis
- Reviewing only the first and last pages
- Sampling only records that are newest
- Selecting pages based on aesthetic layout
Correct Answer: Random or statistically based sampling focusing on critical steps and trend analysis
Q18. For electronic Trial Master File (eTMF) audits, which capability is most critical to demonstrate compliance?
- Ability to export bulk marketing lists
- Searchable indexing, controlled access, versioning, and an audit trail evidencing document lifecycle
- Multiple color themes for the user interface
- Integration with social media platforms
Correct Answer: Searchable indexing, controlled access, versioning, and an audit trail evidencing document lifecycle
Q19. What is the appropriate response timeline to regulatory inspectional findings such as an FDA 483 for a pharmaceutical site?
- Submit a prompt, well-documented written response with corrective and preventive actions and timelines, typically within 15 business days
- Ignore the 483 and wait for further action
- Respond verbally without documentation
- Request unlimited time to prepare without interim actions
Correct Answer: Submit a prompt, well-documented written response with corrective and preventive actions and timelines, typically within 15 business days
Q20. Which training focus will most improve a site’s readiness for documentation-focused audits?
- Advanced sales techniques
- Good documentation practices, ALCOA+ principles, and proper use of controlled templates and electronic systems
- Interior decorating for the documentation office
- Unstructured note-taking methods
Correct Answer: Good documentation practices, ALCOA+ principles, and proper use of controlled templates and electronic systems
